Compare Vertex Pharmaceuticals Incorporated (VRTX) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertex Pharmaceuticals Incorporated vs Zoom Video Communications, Inc. — how do they compare? Vertex Pharmaceuticals Incorporated trades at $503.25 (market cap $127.55B), while Zoom Video Communications, Inc. trades at $95.24 (market cap $27.62B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 4.6× Zoom Video Communications, Inc.'s market cap, and Zoom Video Communications, Inc. is more actively traded (3,913,188 versus 1,487,944). Which is the better fit depends on your goals — on Pluang, investors hold Vertex Pharmaceuticals Incorporated for 120 Days and Zoom Video Communications, Inc. for 92 Days on average.
| VRTX | ZM | |
|---|---|---|
Market Cap | $127.55B | $27.62B |
Volume | 1,487,944 | 3,913,188 |
Sector | Health | Technology |
52-Week High | $557.96 | $111.88 |
52-Week Low | $407.37 | $72.72 |
Typical Hold Time | 120 Days | 92 Days |
Enterprise Value | $121.68B | $20.43B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vertex Pharmaceuticals (VRTX) trades at $505.64, up 0.63% on the day, with a bearish technical signal despite a neutral oscillator reading. The company reported strong 2025 revenue of $12.00B and net income of $3.95B, with a net margin of 35%. Recent positive Phase 2b data for its kidney disease drug inaxaplin highlights pipeline expansion beyond cystic fibrosis dominance. Analyst consensus is strongly bullish with an 83.9% buy rating and a $573.50 price target, implying 13.4% upside.
The outlook for VRTX is positive, driven by its profitable core business and promising pipeline, but faces risks from clinical trial outcomes and competitive pressures. The stock's current valuation at a P/E of 29.45 is reasonable given its growth prospects, though investors should monitor execution on new drug approvals and market adoption.
Zoom Communications (ZM) trades at $94.77, up 0.61% with a bullish technical outlook. The stock shows strong profitability with 77.3% gross margins and 65.19% net income margin, supported by recent earnings beats. Analyst consensus targets $118.08 with 38.8% buy ratings. Recent AI product launches and board appointments signal strategic growth initiatives.
Zoom presents a compelling investment case with attractive valuation (P/E 8.79) and robust profitability, though near-term risks include competitive pressures and reliance on international sales. The stock's proximity to resistance at $95 requires monitoring, but institutional interest and AI-driven revenue initiatives support long-term upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
